We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
- Authors
Galasko, D; Chang, L; Motter, R; Clark, C M; Kaye, J; Knopman, D; Thomas, R; Kholodenko, D; Schenk, D; Lieberburg, I; Miller, B; Green, R; Basherad, R; Kertiles, L; Boss, M A; Seubert, P
- Abstract
To evaluate cerebrospinal fluid (CSF) levels of amyloid beta protein ending at amino acid 42 (Abeta42) and tau as markers for Alzheimer disease (AD) and to determine whether clinical variables influence these levels.
- Publication
Archives of neurology, 1998, Vol 55, Issue 7, p937
- ISSN
0003-9942
- Publication type
Journal Article
- DOI
10.1001/archneur.55.7.937